Csl%2520behring

Commonwealth Serum Laboratories (CSL) Behring

https://www.cslbehring.com

Overview

  • Organization TypeGoods Supplier, Service Providers
  • Staff10,000+
  • HeadquartersUnited States
  • Founded1904
The Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war. Over the ensuing years CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases. CSL Limited was incorporated in 1991 and listed on the Australian Securities Exchange (ASX) in 1994. Since then, CSL has acquired a number of companies. They include: Aventis Behring, which is now known as global biotech leader CSL Behring, U.S. plasma collector Nabi, which helped to form the world's premier plasma collection company in CSL Plasma, the Novartis influenza vaccine business, now integrated and known as Seqirus, the world's second largest influenza vaccines company and Calimmune, a leader in gene-modification and cell delivery technology. Their combined and rich histories make CSL the innovative global leader it is today. It began with a promise. More than 100 years ago, CSL was formed to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. They offer the broadest range of quality plasma-derived and recombinant therapies in their industry. Their ability to innovate and deliver life-saving medicines for patients with unmet medical needs around the world has earned us a reputation for always putting patients first. They are CSL Behring and we are driven by our promise.

Where is Commonwealth Serum Laboratories (CSL) Behring
Projects1Location of contracts awarded

Contact Commonwealth Serum Laboratories (CSL) Behring

Company Offices
  • United States (headquarters)
  • King of Prussia
  • 1020 First Avenue King of Prussia, PA USA